Cronos Group Inc (TSE:CRON)’s share price traded down 5.7% during mid-day trading on Thursday . The stock traded as low as C$15.13 and last traded at C$15.16. 375,453 shares traded hands during trading, a decline of 80% from the average session volume of 1,862,158 shares. The stock had previously closed at C$16.07.

CRON has been the subject of several research analyst reports. Canaccord Genuity upped their price objective on shares of Cronos Group from C$9.00 to C$17.00 in a report on Monday. GMP Securities upped their price objective on shares of Cronos Group from C$14.00 to C$24.00 in a report on Monday. Finally, Cormark upped their price objective on shares of Cronos Group from C$10.00 to C$17.00 in a report on Monday.

The company has a quick ratio of 5.74, a current ratio of 9.02 and a debt-to-equity ratio of 2.58.

WARNING: This article was first posted by Daily Political and is owned by of Daily Political. If you are reading this article on another publication, it was stolen and reposted in violation of US & international copyright and trademark laws. The original version of this article can be accessed at https://www.dailypolitical.com/2018/12/13/cronos-group-cron-shares-down-5-7.html.

Cronos Group Company Profile (TSE:CRON)

Cronos Group Inc, formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations “MMPR”. The firm typically invests in companies based in Canada.

Featured Article: Capital gains and your 401(k) or IRA

Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.